GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo Global Exchange(s) Pte Ltd (OTCPK:IGEX) » Definitions » Net Income (Continuing Operations)

Indo Global Exchange(s) Pte (Indo Global Exchange(s) Pte) Net Income (Continuing Operations) : $0.00 Mil (TTM As of Oct. 2017)


View and export this data going back to 2009. Start your Free Trial

What is Indo Global Exchange(s) Pte Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Indo Global Exchange(s) Pte's Net Income (Continuing Operations) for the three months ended in Oct. 2017 was $0.00 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Oct. 2017 was $0.00 Mil.

Indo Global Exchange(s) Pte Net Income (Continuing Operations) Historical Data

The historical data trend for Indo Global Exchange(s) Pte's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo Global Exchange(s) Pte Net Income (Continuing Operations) Chart

Indo Global Exchange(s) Pte Annual Data
Trend Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14 Jul15 Jul16 Jul17
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.43 -4.60 -2.45 -

Indo Global Exchange(s) Pte Quarterly Data
Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Indo Global Exchange(s) Pte Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Oct. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo Global Exchange(s) Pte  (OTCPK:IGEX) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Indo Global Exchange(s) Pte Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Indo Global Exchange(s) Pte's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo Global Exchange(s) Pte (Indo Global Exchange(s) Pte) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo Global Exchange(s) Pte Ltd (OTCPK:IGEX) » Definitions » Net Income (Continuing Operations)
Comparable Companies
PHIL AAMTF QMCI DIGAF GAHC IFMI PNPFF GOPH MNTR FGCO TST NHLD FBRC CSGGF SIEB CURN JMP AMRK CFLSF AC
Traded in Other Exchanges
N/A
Address
6400 S. Fiddlers Green, No. 250 No.1012, Greenwood Village, CO, USA, 80111
Website
https://www.indogloex.com
Indo Global Exchange(s) Pte Ltd is a holding company. The company is focusing on developing assets within the pharmaceutical and nutraceutical industries.